Zobrazeno 1 - 10 of 231 pro vyhledávání: '"L. Debusscher"'
1
Immunological Definition of Acute Minimally Differentiated Myeloid Leukemia (MO) and Acute Undifferentiated Leukemia (AUL)
Autor: L Debusscher, Pierre Stryckmans, Michel Bernier, Nadine Deleeuw, Dominique Bron, M Massy
Publikováno v: Leukemia & Lymphoma. 18:13-17
Immunophenotyping has become an important tool in the diagnosis of acute leukemia for several reasons. Indeed the use of a standardized panel of monoclonal antibodies (MoAb) to B and T cells, and myeloid cells, as well as non lineage restricted antig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76c4938a6e55cb917622cf71faa5056
https://doi.org/10.3109/10428199509075297
Zobrazit plný text záznamu
2
Large Granular Lymphocyte Proliferative Disease: 21 Belgian Cases And Review Of The Literature
Autor: P. Lacor, André Delannoy, Walter Feremans, Pg. Pierre, R. Debock, Augustin Ferrant, André Bosly, L Debusscher, B. Vancamp, A. Vanhoof, Jl. Michaux
Publikováno v: Acta Clinica Belgica. 47:21-29
We report the findings in 21 Belgian patients (12 males and 9 females, median age 61 years) with LGLPD. Symptoms at presentation included infection (n = 9), weight loss (n = 5), asthenia (n = 9). pruritus (n = 2) and arthralgia (n = 7). Four patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c174e3bad4376d5e542fc9111266afc
https://doi.org/10.1080/17843286.1992.11718206
Zobrazit plný text záznamu
3
Total body irradiation: Clinical experience at the institute Jules Bordet
Autor: L. Debusscher, A. Piron, René Regnier, P. Van Houtte
Publikováno v: Radiotherapy and Oncology. 18:128-131
Our clinical experience with 58 patients receiving TBI as part of their treatment for a malignant hematopoietic disease suggests the following comments: • 6 daily fractions of 2 Gy given over 6 days have a similar antitumoral effect as a single dos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4f963a9adf7d02f82d49cc7abf1ed84
https://doi.org/10.1016/0167-8140(90)90192-y
Zobrazit plný text záznamu
4
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study
Autor: Marie Josèphe André, Christophe Ravoet, Anne Soree, Valérie Robin, André Bosly, Philippe Mineur, Dominique Bron, Hakim El Housni, Philippe Martiat, L Debusscher
Publikováno v: Annals of hematology. 87(11)
Although an activating mutation of Ras is commonly observed in myelodysplastic syndrome (MDS), the role of Ras in the natural history of MDS remains largely unknown. We prospectively studied efficiency and tolerance of lonafarnib, a compound able to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39da4e808dbffebc1dfdc937baa37b41
https://pubmed.ncbi.nlm.nih.gov/18641985
Zobrazit plný text záznamu
5
De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema
Autor: Francesco Feoli, Muriel Greuse, Laurence Lespagnard, Jean-Louis Dargent, L Debusscher, Dominique Bron
Publikováno v: Leukemialymphoma. 46(5)
We report the case of a 79-year-old woman with a longstanding lymphedema of the right arm who developed a skin lymphoma involving the right wrist area. Microscopically, the lesion was composed of numerous centroblasts infiltrating both the dermis and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a78bc76df6fdbf3f74de80b6f46247c
https://pubmed.ncbi.nlm.nih.gov/16019518
Zobrazit plný text záznamu
6
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Autor: A, Gratwohl, J, Hermans, A, van Biezen, W, Arcese, L, Debusscher, P, Ernst, A, Ferrant, F, Frassoni, G, Gahrton, A, Iriondo, H J, Kolb, H, Link, D, Niederwieser, T, Ruutu, W, Siegert, F E, Zwaan
Publikováno v: British journal of haematology. 95(3)
A total of 229 patients with chronic myeloid leukaemia (CML) in chronic phase were randomized between 1986 and 1990 to receive or not receive additional splenic irradiation as part of their conditioning prior to bone marrow transplantation (BMT). Bot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a7da215d6f34b8d5f816a755ca0ac50
https://pubmed.ncbi.nlm.nih.gov/9136980
Zobrazit plný text záznamu
7
Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia
Autor: Peter B. Ernst, Augustin Ferrant, A. Iriondo, Hartmut Link, Alois Gratwohl, Jean-Paul Vernant, Francesco Frassoni, Tapani Ruutu, L. Debusscher, Norbert Schmitz, F. E. Zwaan, Anja van Biezen, Dietger Niederwieser, Wolfgang Siegert, H. J. Kolb, Jo Hermans, William Arcese, A. Torres-Gomez, G. Gahrton, J. F. Apperley, Anton Schattenberg
Publikováno v: British Journal of Haematology, 95, pp. 494-500
British Journal of Haematology, 95, 3, pp. 494-500
British Journal of Haematology, 95, 494-500
A total of 229 patients with chronic myeloid leukaemia (CML) in chronic phase were randomized between 1986 and 1990 to receive or not receive additional splenic irradiation as part of their conditioning prior to bone marrow transplantation (BMT). Bot
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f40b17e5171f6aa1473181e2cdfd57
https://hdl.handle.net/2066/189065
Zobrazit plný text záznamu
8
Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: update of a prospective randomized study
Autor: Jo Hermans, William Arcese, Dietger Niederwieser, A. Gratwohl, Anja van Biezen, T. Ruutu, Kolb Hj, A. Iriondo, Hartmut Link, T. de Witte, G. Gahrton, A. Torres-Gomez, Augustin Ferrant, N. Schmitz, Wolfgang Siegert, Francesco Frassoni, P. Ernst, J P Vernant, F. E. Zwaan, L Debusscher
Publikováno v: Leukemialymphoma. 11
Two hundred and twenty-nine patients with chronic myeloid leukaemia in chronic phase awaiting bone marrow transplantation from an HLA-identical sibling donor were randomized as part of their conditioning, to receive splenic irradiation (SI+, 115 pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abf9084a63e62e3264386ff8f2abbf8
https://pubmed.ncbi.nlm.nih.gov/8251901
Zobrazit plný text záznamu
9
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study
Autor: A, Gratwohl, J, Hermans, A, von Biezen, W, Arcese, T, de Witte, L, Debusscher, P, Ernst, A, Ferrant, F, Frassoni, G, Gahrton
Publikováno v: Bone marrow transplantation. 10(2)
A total of 239 patients with chronic myeloid leukaemia (CML) in chronic phase awaiting bone marrow transplantation (BMT) from an HLA-identical sibling donor were randomized to receive, as part of their conditioning, splenic irradiation (SI+) or no sp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::965c0e60fe76dc8cd7215f2faa6fe4d9
https://pubmed.ncbi.nlm.nih.gov/1525604
Zobrazit plný text záznamu
10
[Bone marrow autograft in malignant hemopathies. The Team of the Sterile Unit]
Autor: D, Bron, L, Debusscher, M, Bernier, R, Badjou, P, Crombez, P, Stryckmans
Publikováno v: Revue medicale de Bruxelles. 13(5)
Only in the last decade have autologous grafts begun to be studied extensively. Their most attractive feature is the avoidance of GVHD. However, GVHD has antitumoral effect on residual leukemic cells called "graft versus leukemia" effect and better u
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a2107ef9dda83fe8519fd6eb0c7d0512
https://pubmed.ncbi.nlm.nih.gov/1609191
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje